ETF

ARK Genomic Revolution ETF A USD Acc

ISIN
IE000O5M6XO1

How good is this fund, really?

See the rating in the app

About ARK Genomic Revolution ETF A USD Acc

ARK Genomic Revolution ETF A USD Acc invests actively in global shares of companies linked to the genomic revolution: businesses using advances in genomic sequencing, analysis, synthesis or instrumentation, as well as areas such as bionic devices, bioinformatics, molecular medicine and agricultural biotechnology, across sectors including healthcare and information technology. It belongs to ARK Invest UCITS ICAV, with IQ EQ Fund Management (Ireland) Limited as manager. Stock picking blends top-down thematic research with bottom-up company analysis, including ESG considerations, and the thematic screen looks for technologies seen as contributing to at least two UN Sustainable Development Goals. Income is reinvested. Ongoing charges: 0.75%. Risk: 7 on a scale of 1 to 7, the highest category.

Watch this fund for free Add ARK Genomic Revolution ETF A USD Acc to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy ARK Genomic Revolution ETF A USD Acc — platforms and fees

Sold on 4 platforms we follow.

ARK Genomic Revolution ETF A USD Acc — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds